MEDIVIR, INTERIM REPORT 1 January - 30 September 2007 • Consolidated net sales were SEK 80.8 (88.1) m in the period. • The loss after tax amounted to SEK -138.1 (-115.0) m. • Liquid funds amounted to SEK 264.0 (216.9) m as of 30 September. • Earnings per share were SEK -8.23 (-8.91). FOR MORE INFORMATION, PLEASE CONTACT: Rein Piir, CFO and VP, Investor Relations: +46 (0)8 5468 3123 or +46 (0)70 853 7292.
MEDIVIR, INTERIM REPORT 1 January - 30 September 2007
| Source: Medivir AB